Rein Therapeutics, Inc. (RNTX) › Net IncomeRein Therapeutics, Inc. (RNTX) — Net IncomeAnnual figures by fiscal year, from SEC filings.2015: -$12.88M2016: -$18.12M2017: -$22.60M2018: -$31.55M2019: -$29.37M2020: -$27.33M2021: -$26.16M2022: -$27.33M2023: -$15.73M2024: -$62.88M2025: -$49.87M-$49.87M2015Net Income (USD)2025Fiscal YearNet IncomeChange YoY2025-$49.87M+20.7%2024-$62.88M-299.7%2023-$15.73M+42.4%2022-$27.33M-4.5%2021-$26.16M+4.3%2020-$27.33M+6.9%2019-$29.37M+6.9%2018-$31.55M-39.6%2017-$22.60M-24.7%2016-$18.12M-40.7%2015-$12.88M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share